Skip to main content
Premium Trial:

Request an Annual Quote

MediChem Shareholders Give Green Light to DeCode Merger

NEW YORK, March 14 - MediChem Life Sciences shareholders on Thursday approved the company's merger with DeCode Genetics. The merger, originally expected to close next quarter, is now expected to be finalized tomorrow.

 

DeCode announced its plans to acquire MediChem in January in a stock-swap deal valued at roughly $84 million. The Icelandic population genomics firm hopes to bolster its chemistry and structural proteomics technology through the deal, speeding its progress toward in-house drug discovery and development.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.